Although the introduction of universal pertussis immunisation in infants has greatly reduced
the number of reported cases in infants and young children, disease incidence has been …

Immunisation during pregnancy is a relatively new strategy, and is currently limited to
tetanus, pertussis, and influenza vaccines. None of these vaccines were developed …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

Combination vaccines containing a monocomponent acellular pertussis (aP) vaccine,
manufactured at Statens Serum Institut (SSI), Denmark, have successfully controlled …

The measurement of IgG anti-pertussis toxin (IgG anti-PT) antibodies by ELISA is a
frequently used method for studying the antibody responses after pertussis vaccination and …

We prospectively measured pertussis-specific antibodies 9–15 months after delivery in
women immunized with tetanus, diphtheria, and acellular pertussis (Tdap) after the 20th …

Reduced-antigen-content diphtheria–tetanus–acellular-pertussis (dTpa) vaccines are
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …

Pertussis or whooping cough is increasingly being shown to be a respiratory infection
affecting the elderly and a significant percentage of older people infected with Bordetella …

Pertussis is a highly contagious respiratory infection characterized by prolonged cough and
inspiratory whoop. Despite widespread vaccination of children aged< 7 years, its incidence …